NEW YORK (360Dx) – Quidel on Wednesday announced it has received approval from Japanese regulators for the use of the company's Sofia Influenza A+B Fluorescent Immunoassay on the Sofia Fluorescent Immunoassay Analyzer.

The approval came from Japan's Pharmaceuticals and Medical Devices Agency. An estimated 13 million to 16 million cases of influenza in Japan were confirmed each year between 2010 and 2014, Quidel said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.